Ingredion (NYSE: INGR) details next steps in Tate & Lyle all-cash acquisition
Ingredion (NYSE: INGR) has provided an update on its all-cash acquisition of Tate & Lyle PLC, announcing that Tate & Lyle has published a Scheme Document. This document outlines the court-sanctioned scheme of arrangement for the deal, which will be voted on by Tate & Lyle shareholders at meetings scheduled for July 28, 2026. The filing clarifies that this is a procedural step and not an offer, reminding shareholders to base decisions solely on the Scheme Document.
Ingredion publishes Tate & Lyle scheme document ahead of July 28 shareholder votes
Ingredion announced that Tate & Lyle has published the Scheme Document for Ingredion’s recommended all-cash acquisition. Shareholder meetings for the scheme and related resolutions are scheduled for July 28, 2026. The document contains full terms and voting instructions, with shareholders urged to review it before voting.
Ingredion (INGR) Completes $165M Sale of Rafhan Maize Stake
Ingredion (INGR) has completed the sale of a 51% stake in Rafhan Maize for $165M, retaining a 20% ownership interest. The company also announced a recommended all-cash offer to acquire Tate & Lyle for approximately $5 billion, a deal expected to generate $130M in synergies. Ingredion plans to finance the acquisition through existing cash and new debt.
LSV GLOBAL MANAGED VOLATILITY FUND's Ingredion Inc(INGR) Holding History
As of April 30, 2026, LSV GLOBAL MANAGED VOLATILITY FUND held 650 shares of Ingredion Inc (INGR), valued at $72,630, which constitutes 0.72% of its stock portfolio. The fund has made one purchase and two sales of INGR since the initial trade in Q4 2019, with an estimated gain of $640 (0.49%) on its current holdings.
INGR - Ingredion Inc Latest SEC Filings
This article provides a detailed financial overview of Ingredion Inc (INGR), including its latest stock performance, key financial metrics, analyst ratings, and insider transaction data. It highlights the company's market capitalization, income, sales, dividend information, and various profitability ratios, along with recent EPS and sales growth figures.
Form 4 Ingredion Inc For: 2 July By Investing.com
This article from Investing.com reports on a Form 4 filing for Ingredion Inc. for July 2nd. The filing is a routine SEC document used to report changes in beneficial ownership of a company's securities by insiders. The article offers no further details about the specific content of the Form 4.
Ingredion (INGR) outside director granted 1,516 RSUs as 2026 equity retainer
Ingredion Inc. outside director T. Kenneth Escoe was granted 1,516 restricted stock units (RSUs) as part of the company's 2026 annual equity retainer. These RSUs are valued at $98.97 per unit and will vest on May 19, 2027. The grant aligns with the company's shift to an annual stockholder meeting-aligned compensation cycle for directors.
Ingredion (NYSE: INGR) director T. Kenneth Escoe files initial Form 3
Ingredion Inc. director T. Kenneth Escoe has filed an initial Form 3, an insider ownership report, indicating his new status as a reporting person subject to insider disclosure rules. This filing establishes his beneficial ownership but does not list any specific share holdings, transactions, or derivative securities, serving primarily as an initial statement of his relationship to the company. The report confirms he is a director but not a 10% owner.
Ingredion (INGR) director receives 265 phantom stock units in deferred pay
Ingredion Inc. director Charles V. Magro received 265 phantom stock units on June 30, 2026, as deferred compensation under the company’s Non-Qualified Deferred Compensation Plan. The units were allocated based on a closing price of $94.71 per share, with each unit representing the right to receive one share of Ingredion common stock in the future. Following this grant, Magro now holds a total of 500 phantom stock units, reflecting deferred, non-cash compensation.
Ingredion (NYSE: INGR) SVP granted new phantom stock award
Ingredion Inc.'s SVP, Global Operations and CSCO, David Eric Seip, was granted 18.44 phantom stock units on June 30, 2026, as part of his compensation under the company's Non-Qualified Deferred Compensation Plan. Valued at $94.711 per unit, this award increased his total phantom stock holdings to 13,236.1041 units. This transaction represents a compensation award and not an open-market stock purchase or sale.
Ingredion Sells Majority Stake in Rafhan Maize
Ingredion has sold 51% of its stake in Rafhan Maize Products Co. Ltd. for $165 million to a purchaser group led by Nishat Hotels and Properties Limited. Ingredion retains a 20% minority interest with a put option and maintains commercial agreements. Analysts currently rate INGR as a Hold with a $120 price target, citing strong profitability and valuation but cautious near-term outlook due to market disruptions.
Ingredion Completes Sale of Majority Equity Stake in Pakistan Business
Ingredion Incorporated has completed the sale of a 51% interest in Rafhan Maize, a Pakistan-based food and industrial ingredients manufacturer, to a group led by Nishat Hotels and Properties Ltd. The transaction, valued at approximately $165 million, allows Ingredion to retain a 20% ownership stake. This move aims to transform Ingredion's portfolio, reduce earnings volatility, and free up investment capital for higher-growth businesses, while maintaining access to Middle East and South Asia markets.
Press Release: Ingredion Completes Sale of Majority Equity Stake in Pakistan Business
Ingredion has completed the sale of a majority equity stake in its Pakistan-based business, Ingredion Pakistan (Private) Limited, to a local investor group led by Allied Group. Ingredion will retain a 15% minority equity stake in the divested entity and continue to support the business's food and beverage customers with its portfolio of starch and sweetener solutions from its global manufacturing network. The financial terms of the transaction were not disclosed.
Ingredion completes sale of 51% stake in Rafhan Maize for $165m
Ingredion has completed the sale of a 51% interest in Rafhan Maize to Nishat Hotels and Properties Ltd. for approximately $165 million, while retaining a 20% ownership in the Pakistani company. This divestiture aims to transform Ingredion's portfolio, reduce earnings volatility, and free up capital for higher-growth businesses, with the company noting that its stock is currently undervalued according to InvestingPro. Ingredion also recently announced a significant acquisition of Tate & Lyle for $5 billion and the purchase of Benicaros, a prebiotic fiber brand.
Ingredion Closes Sale of 51% Rafhan Maize Stake for $165 Million
Ingredion (INGR) has completed the sale of its 51% stake in Rafhan Maize for $165 million, as reported by MT Newswires. This transaction comes amidst other significant corporate movements for Ingredion, including securing a substantial delayed-draw term loan to fund its acquisition of Tate & Lyle.
Ingredion (NYSE: INGR) nets $165M from Rafhan Maize stake sale, keeps 20%
Ingredion (NYSE: INGR) has successfully completed the sale of a 51% stake in Rafhan Maize Products Co. Ltd. to a purchaser group led by Nishat Hotels and Properties Limited for approximately $165 million in cash. Despite the sale, Ingredion will retain a 20% minority ownership interest in the Pakistan-based company, which generated $250 million in net sales in 2025. The deal also includes a shareholders agreement with a put option for Ingredion and new manufacturing, supply, and distribution agreements to maintain commercial ties.
Ingredion Completes Sale of Majority Equity Stake in Pakistan Business
Ingredion Incorporated (NYSE: INGR) has completed the sale of a 51% interest in Rafhan Maize, a Pakistani food and industrial ingredients manufacturer, to a group led by Nishat Hotels and Properties Ltd. The transaction, valued at approximately $165 million, allows Ingredion to retain a 20% ownership stake. This move aims to transform Ingredion's portfolio, reduce earnings volatility, and free up investment dollars for higher-growth businesses, while maintaining access to Middle East and South Asia markets.
Ingredion cashes out of most of its Pakistan business for $165M
Ingredion (NYSE: INGR) has completed the sale of a 51% equity interest in its Pakistan business, Rafhan Maize, for approximately $165 million to a purchaser group led by Nishat Hotels and Properties. The company will retain a 20% ownership stake in Rafhan Maize. This strategic move aims to reduce earnings volatility, unlock capital for higher-growth investments, and maintain access to Middle East and South Asia markets, despite the Pakistan business generating unaudited net sales of $250 million in 2025.
Top 3 Risk Off Stocks That Could Lead To Your Biggest Gains This Month
This article identifies three "oversold" consumer staples stocks—Ingredion Inc (NYSE: INGR), Dingdong (Cayman) Ltd (NYSE: DDL), and Coffee Holding Co., Inc. (NASDAQ: JVA)—that could present buying opportunities. These companies are highlighted because their Relative Strength Index (RSI) is near or below 30, indicating they may be undervalued. The article provides recent company updates, stock performance data, and their current RSI values for each.
ETFs Investing in Ingredion Incorporated Stocks
This article lists various ETFs that include Ingredion Incorporated (INGR) stocks in their holdings. It provides detailed financial information for each ETF, such as market value, weight of INGR, issuer, management style, expense ratio, assets under management (AUM), and price performance. The list aims to make investing in Ingredion Incorporated more accessible by showcasing diverse ETF options with different investment strategies and risk profiles.
Ingredion stock hits 52-week low at 96.51 USD
Ingredion's stock has dropped to a 52-week low of $96.51, representing a significant 28.68% decline over the past year. Despite this downturn, InvestingPro analysis suggests the stock might be undervalued, trading at a P/E ratio of 9.33 and a PEG ratio of 0.92, and the company has consistently paid dividends for 29 years. Recent strategic moves include the acquisition of Tate & Lyle for $5 billion and Benicaros, although analyst opinions on these developments are mixed.
Enterprise value to revenue forward of Ingredion Incorporated – NYSE:INGR
This article provides financial data for Ingredion Incorporated (NYSE: INGR), specifically focusing on its enterprise value to revenue forward. The content appears to be a stub or a data point from a financial platform like TradingView, offering a snapshot of a single financial metric for the company.
Enterprise value to revenue forward of Ingredion Incorporated – FWB:CNP
This article focuses on the forward enterprise value to revenue for Ingredion Incorporated, traded on the Frankfurt Stock Exchange under the symbol CNP. It appears to be a financial data snippet from TradingView, indicating a specific financial metric for the company. The content primarily lists the company, stock exchange, and a brief description of the metric.
Price to earnings forward of Ingredion Incorporated – NYSE:INGR
This article displays the "Price to earnings forward" metric for Ingredion Incorporated (NYSE: INGR). It is a financial data point presented within the TradingView platform interface, indicating a specific valuation measure for the company. The content itself provides the value and change for this metric, attributing the data to financial information providers.
Ingredion Secures $1.48 Billion Delayed-Draw Term Loan to Fund Tate & Lyle Acquisition
Ingredion has secured a $1.48 billion delayed-draw term loan to finance its acquisition of the outstanding shares of PureCircle from Tate & Lyle. The loan, which will fund the remaining 49.33% stake in PureCircle, demonstrates Ingredion's strategic move to fully integrate the stevia solutions provider. This financial step highlights Ingredion's commitment to expanding its portfolio of sustainable, plant-based ingredients.
Price to earnings forward of Ingredion Incorporated – FWB:CNP
This page from TradingView displays financial information for Ingredion Incorporated (FWB:CNP), focusing specifically on its price-to-earnings forward ratio. The content indicates that the market was closed with no trades. It also details the various data sources used and lists the extensive features and services offered by TradingView.
Price to sales forward of Ingredion Incorporated – NYSE:INGR
This article provides financial data specifically focusing on the "Price to sales forward" metric for Ingredion Incorporated (NYSE: INGR). It lists the stock symbol, exchanges, and acknowledges that the market is closed without any trades. The content is presented as a data point within a financial platform, indicating a specific value and historical change percentage for this metric.
Price to book forward of Ingredion Incorporated – GETTEX:CNP
This article provides financial data for Ingredion Incorporated (CNP) on the Gettex exchange, specifically focusing on its Price to Book Forward metric. The content indicates that the market for this stock is currently closed with no trades recorded.
Ingredion Secures $1.475 Billion Delayed-Draw Term Loan to Fund Tate & Lyle Acquisition
Ingredion has secured a $1.475 billion senior unsecured delayed-draw term loan facility to finance its proposed acquisition of Tate & Lyle, associated debt refinancing, and transaction costs. The facility includes a $500 million Tranche A-1 maturing in three years and a $975 million Tranche B-1 maturing in five years, both with annual amortization. JPMorgan Chase Bank acted as the administrative agent for the syndicate of lenders.
Ingredion (NYSE: INGR) lines up $1,475,000,000 term loan to fund Tate & Lyle deal
Ingredion Incorporated (NYSE: INGR) has secured a new senior unsecured delayed draw term loan facility totaling $1.475 billion. This financing is intended to fund its acquisition of Tate & Lyle PLC, refinance existing Tate & Lyle debt, and cover associated costs. The term loan replaces a portion of a previous bridge loan, providing more stable, longer-dated funding for the acquisition.
Enterprise value to EBITDA forward of Ingredion Incorporated – NYSE:INGR
The article provides information regarding the enterprise value to EBITDA forward for Ingredion Incorporated (NYSE: INGR). It lists the stock ticker and mentions that the market was closed at the time of publication, with no trades occurring. The page seems to be a financial data portal displaying key metrics for the company.
Ingredion (INGR): Buy, Sell, or Hold Post Q1 Earnings?
Ingredion's stock has declined by 12.9% over the past six months, underperforming the S&P 500. The article suggests caution due to decreasing revenue, slim projected revenue growth of 1.7% for the next 12 months, and a dropping free cash flow margin. Despite a seemingly cheap forward P/E of 8.6x, the analysis concludes that Ingredion's shaky fundamentals make it a less attractive investment compared to other opportunities.
Ingredion stock hits 52-week low at 97.1 USD By Investing.com
Ingredion Inc's stock has hit a 52-week low of $97.10, representing a 30.03% decline over the past year. Despite this, InvestingPro data suggests the stock is undervalued with a P/E ratio of 9.46 and a dividend yield of 3.35%. The company recently announced a $5 billion acquisition of Tate & Lyle PLC and the purchase of the Benicaros prebiotic fiber brand, leading to mixed analyst ratings regarding its future outlook.
Ingredion stock hits 52-week low at 97.1 USD
Ingredion's (INGR) stock has fallen to a 52-week low of $97.10, representing a 30.03% decline over the past year. Despite this, InvestingPro data suggests the stock is undervalued, offering a P/E ratio of 9.46 and a 3.35% dividend yield. The company recently announced a major acquisition of Tate & Lyle PLC for $5 billion and the prebiotic fiber brand Benicaros, leading to a reiterated Buy rating from Benchmark but a downgrade to Perform from Oppenheimer due to acquisition complexities.
INGR - Ingredion's Future PE of 9.5x Will Make Waves in the Investment Community
The author, AgWiz, believes Ingredion (INGR) is undervalued by the market due to its focus on short-term acquisition uncertainty, while overlooking the company's long-term transformation into a specialty-focused ingredients company through the acquisition of Tate & Lyle. The author projects that successful integration, combined with Ingredion's strong ROIC and free cash flow, could lead to a significantly higher valuation over the next 3-5 years, potentially delivering 8-12% annual returns for long-term shareholders.
Ingredion Inc (INGR) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Ingredion Inc (INGR), outlining major institutional holders and their proportion of shares. It includes a breakdown of shareholder types, institutional shareholding over several quarters, and recent shareholder activity with changes in holdings for key institutions. The article also lists various ETFs that hold INGR shares.
Ingredion Inc (INGR) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Ingredion Inc (INGR), detailing its current price momentum score, support and resistance levels, and various technical indicator readings. It shows that INGR's price momentum score is 6.70, ranking 46 out of 95 in the Food & Tobacco industry, with the stock trading between a resistance of 103.65 and a support of 95.57. The analysis concludes with strong "Sell" signals across both individual indicators and moving averages, suggesting a bearish outlook based on technical data.
[Form 4] Ingredion Inc Insider Trading Activity
Ingredion Inc. senior vice president David Eric Seip reported an acquisition of 17.206 phantom stock units, tied to the company's common stock, under the Non-Qualified Deferred Compensation Plan. This transaction, based on a closing share price of $101.5000 on June 15, 2026, increases Seip's total holdings to 13,217.6641 phantom stock units. Each unit represents the right to receive one share of Ingredion common stock in the future.
Ingredion (NYSE: INGR) SVP receives phantom stock award under deferred plan
Michael J. Leonard, Senior Vice President and CIO of Ingredion Inc. (NYSE: INGR), received an award of 33.65 phantom stock units under the company's Non-Qualified Deferred Compensation Plan. The units were granted at a reference price of $101.51 each on June 15, 2026, bringing his total holdings to 1,682.78 phantom stock units. Each unit represents the right to receive one share of Ingredion common stock.
Ingredion Incorporated $INGR Stock Holdings Lessened by Fieldview Capital Management LLC
Fieldview Capital Management LLC significantly reduced its holdings in Ingredion Incorporated ($INGR) by 68.1% in the fourth quarter, selling 33,260 shares and retaining 15,604 shares valued at approximately $1.72 million. Other institutional investors made various adjustments to their positions, with hedge funds and institutional investors collectively owning 85.27% of the stock. Ingredion reported Q1 earnings that missed Wall Street estimates and reaffirmed full-year guidance, while analysts maintain a cautious "Hold" rating with an average price target of $122.43.
Tate & Lyle seen boosting key Ingredion segment
Ingredion's pending acquisition of Tate & Lyle for £2.7 billion ($3.6 billion) is expected to significantly boost Ingredion's "Texture and Healthful Solutions" segment, which focuses on ingredients for healthier products like reduced sugar, more protein and fiber, and simpler labels. The combined entity will generate $10 billion in annual revenue and achieve substantial cost synergies, enhancing Ingredion's global footprint and ability to meet evolving consumer demands for taste, texture, and affordability. Ingredion CEO James P. Zallie highlighted how Tate & Lyle's strengths in pectin, fiber fortification, and soluble fiber complement Ingredion's existing portfolio, creating a more robust and responsive global supplier.
Ingredion Adds Independent Director Kenneth Escoe to Board
Ingredion (INGR) has announced the election of Kenneth Escoe as an independent director to its board, effective July 1, 2026. Escoe, currently executive vice president of Specialty Products at Illinois Tool Works Inc., brings valuable leadership experience from a Fortune 500 company and nonprofit board service. Analysts currently rate INGR stock as a Hold with a $99.98 price target, while TipRanks' AI Analyst, Spark, deems it Neutral due to solid financials and attractive valuation offsetting weak technicals and near-term headwinds.
Texture, health central to Ingredion’s acquisition of Tate & Lyle
Ingredion's pending acquisition of Tate & Lyle PLC for £2.7 billion ($3.6 billion) aims to capitalize on key ingredient trends such as healthier products and enhanced taste/texture. According to Ingredion CEO James P. Zallie, the combined entity will see over half its revenue from "Texture and Healthful Solutions" and is projected to generate $10 billion in annual revenue and $1.8 billion in adjusted EBITDA. The acquisition is expected to strengthen Ingredion’s formulation expertise, broaden manufacturing capabilities, and create significant cost synergies.
Press Release: Ingredion Names Kenneth Escoe to Board of Directors
Ingredion has announced the appointment of Kenneth Escoe to its Board of Directors, effective July 1, 2026. Escoe brings extensive experience in global operations, supply chain management, and enterprise technology, having worked with major companies like PepsiCo and Procter & Gamble. This strategic addition is expected to support Ingredion's long-term growth and operational excellence.
Ingredion Names Kenneth Escoe to Board of Directors
Ingredion Incorporated (NYSE: INGR) has appointed Kenneth Escoe to its board of directors, effective July 1, 2026. Escoe, currently Executive Vice President of Specialty Products at Illinois Tool Works Inc., brings extensive experience in leading capital-intensive businesses and transforming global operations across various commodity and specialty sectors. His background in food and beverage packaging, along with multifunctional expertise in operations, commercial strategy, and M&A, is expected to significantly strengthen Ingredion's long-term growth strategy and board perspectives.
Ingredion (NYSE: INGR) elects Illinois Tool Works executive Kenneth Escoe to board
Ingredion Incorporated (NYSE: INGR) has announced the election of Kenneth Escoe, age 51, to its Board of Directors, with his term commencing on July 1, 2026. Escoe, currently the Executive Vice President of Specialty Products at Illinois Tool Works Inc., qualifies as an independent director under New York Stock Exchange standards. He will receive standard non-management director compensation, including cash and restricted stock units.
Ingredion Incorporated
Ingredion Incorporated (NYSE: INGR) announced the appointment of Kenneth Escoe to its board of directors, effective July 1, 2026. Escoe currently serves as executive vice president of Specialty Products at Illinois Tool Works Inc. The company highlighted his extensive experience in leading capital-intensive businesses, transforming global operations, and his background in food and beverage packaging, which will be valuable to Ingredion's growth strategy.
Ingredion Names Kenneth Escoe to Board of Directors
Ingredion Incorporated (NYSE: INGR) has appointed Kenneth Escoe to its board of directors, effective July 1. Escoe, currently Executive Vice President of Specialty Products at Illinois Tool Works Inc., brings extensive experience in leading capital-intensive businesses and transforming global operations, particularly within the food and beverage packaging sector. The company's leadership anticipates his expertise will significantly contribute to their long-term growth strategy and strengthen their board's decision-making.
Tate & Lyle to be bought by Illinois-based company for $5 billion
Ingredion Incorporated, an Illinois-based global ingredient solutions provider, has announced its acquisition of London-based Tate & Lyle for approximately $5 billion. This transaction aims to combine their expertise and product portfolios to better address consumer needs in the food and beverage industry. The acquisition is expected to finalize in late 2027, with both boards recommending the deal.
Ingredion to Acquire Tate & Lyle for £2.7 Billion; Secures $4.23 Billion Bridge Loan
Ingredion has announced its intention to acquire Tate & Lyle for £2.7 billion (595 pence per share) through an all-cash offer. The transaction, expected to close in the second half of 2027, will be financed by a $4.225 billion bridge loan from JPMorgan. Key shareholders, including Huber Equity and Tate & Lyle directors, have provided irrevocable undertakings to support the deal.
